1, 2-Butylene oxide

Toxic Release Inventory data for 2024. 13 facilities reported releasing 1, 2-butylene oxide.

On-site releases2.3k lb
Off-site transfers40.5k lb
Air emissions2.3k lbstack + fugitive
Water discharges2 lb

Largest 2024 releasers

FacilityStateOn-site (lb)
Louisville Packaging
Louisville
Kentucky632
Enviro Tech International Inc.
Melrose Park
Illinois500
Westlake Us 2 Llc
Westlake
Louisiana291
Pacific Aerospace & Electronics
Wenatchee
Washington153
Trecora Wax Llc
Pasadena
Texas52
Ips Corp
Gardena
California29
Huntsman Petrochemical Llc
Conroe
Texas12
Evonik Industries
Janesville
Wisconsin11
Freeport_olin Bc
Freeport
Texas7
Lyondell Chemical Co
Channelview
Texas7
Altivia Crosby Facility
Crosby
Texas2
Elliott Co Of Indianapoli S Inc.
Indianapolis
Indiana0

About 1, 2-Butylene oxide in the Toxic Release Inventory

The Toxic Release Inventory (TRI) tracks how much of each listed chemical U.S. industrial facilities release into the environment each year. EPA requires facilities in certain industry sectors that manufacture, process, or otherwise use TRI-listed chemicals above threshold amounts to report annually. In 2024, 13 facilities reported releasing 1, 2-butylene oxide to EPA's TRI program.

Releases are spread across all three environmental pathways: 2.3k lb to air (stack and fugitive emissions), 2 lb to water (surface water discharges), and 1 lb to land (landfills, surface impoundments, and land treatment).

TRI data represents reported releases, not measured environmental concentrations. A facility reporting large releases of 1, 2-butylene oxide is not necessarily causing harm at those levels — toxicity, exposure pathways, and local conditions all matter. Conversely, small reported amounts of highly toxic chemicals can pose greater risk than large amounts of less toxic ones. TRI is a transparency tool, not a risk assessment.

For health information about specific chemicals, the Agency for Toxic Substances and Disease Registry (ATSDR) publishes toxicological profiles, and EPA's Integrated Risk Information System (IRIS) provides reference doses and cancer classifications.